Table 2. Comorbidities in patients with CIEDs (n = 612).

CABG, coronary artery bypass graft; CAD, coronary artery disease; CHD, congenital heart defect; CIED, cardiac implantable electronic devices; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease

Comorbidities	Non-Infected Group (n, %)	Infected group (n, %)	p-value
Hypertension	388 (67.1%)	21 (61 %)	.519
Diabetes	347 (60 %)	21 (61%)	.841
Cardiomyopathy	271 (46.9%)	16(47%)	.984
Heart Failure	236 (40.8 %)	11 (32.4%)	.328
CAD	168 (29.1%)	14 (41.2%)	.133
CKD	121 (20.9%)	6 (17%)	.646
Myocardial Infarction	115 (19.9)	7 (20%)	.922
CABG	83 (14.4 %)	4 (11.8%)	.736
Valvular Surgery	58 (10 %)	5 (14.7%)	.384
COPD	47 (8.1%)	0 (00%)	.084
Cancer	40 (6.9%)	0 (0,0%)	.113
Skin Disorder	32 (5.4%)	1 (2.9 %)	.536
CHD	9 (1.6%)	1 (2.9 %)	.536